Medical technology company Tasso announced today it has gained an additional $2.9 million in Phase II SBIR grant funding to advance its HemoLink­ technology. According to a release, Tasso, along with development partner GenTegra,…

Medical technology company Tasso announced on Monday it has secured $2.3 million in grant funding for its HemoLink­ technology. HemoLink is a wearable device that allows users to collect their own blood without special…